Radiation-absorbed dose from 201Tl-thallous chloride

Journal of Nuclear Medicine

Volumn 46, Issue 3, 2005, Pages 502-508

  Thomas, Stephen R ^a   Stabin, Michael G ^b   Castronovo, Frank P ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

201Tl dosimetry; 201Tl thallous chloride; Radiation dosimetry; Radiocontaminants; Testes radiation dose

Indexed keywords

LEAD 203; THALLIUM CHLORIDE TL 201; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; THALLIUM; THALLIUM CHLORIDE;

ARTICLE; CLINICAL ARTICLE; DOSE CALCULATION; DOSIMETRY; DRUG HALF LIFE; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOACTIVE CONTAMINATION; SCINTIGRAPHY; TESTIS; ANTIBODY SPECIFICITY; BODY BURDEN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; RADIOMETRY; RELATIVE BIOLOGIC EFFECTIVENESS; SCINTISCANNING; TISSUE DISTRIBUTION; WHOLE BODY COUNTING;

BODY BURDEN; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; RELATIVE BIOLOGICAL EFFECTIVENESS; TESTIS; THALLIUM; TISSUE DISTRIBUTION; WHOLE-BODY COUNTING;

EID: 17844380794     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Strauss HW, Harrison K, Langan JK, et al. Thallium-201 for myocardial imaging: relation of thallium-201 to regional myocardial perfusion. Circulation. 1975;51: 641-645.
2. Ritchie JL, Hamilton GW, Wackers FJT, eds. Thallium-201 Myocardial Imaging. New York, NY: Raven Press; 1978.
3. 201Tl: instrumentation, technical, and clinical aspects. In: Freeman LM, Weissmann HS, eds. Nuclear Medicine Annual 1985. New York, NY: Raven Press; 1985:233-263.
4. Hudson FR, Dewey DL, Galpine AR, Whittingham AG. Tumor uptake of thallium-201 chloride. Eur J Nucl Med. 1979;4:283-284.
5. Tonami N, Shuke N, Yokoyama K, et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med. 1989;30:997-1004.
6. Charkes ND, Vitti RA, Brooks K. Thallium-201 SPECT increases detectability of thyroid cancer metastases. J Nucl Med. 1990;31:147-153.
7. Lee JK, Tyan YS, Huang WS. Comparison of thallium-201 SPET and CT/MRI in the detection of residual/recurrent squamous cell carcinoma of the oral cavity. Eur J Nucl Med Mol Imaging. 2004;31:528-531.
8. Choong PF, Nizam I, Ngan SY, et al. Thallium-201 scintigraphy: a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy. Eur J Surg Oncol. 2003;29:908-915.
9. Benard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med. 2003;33:148-162.
10. Gimlette TM, Brownless SM, Taylor WH, Shields R, Simkin EP. Limits to parathyroid imaging with thallium-201 confirmed by tissue uptake and phantom studies. J Nucl Med. 1986;27:1262-1265.
11. Gehring PJ, Hammond PB. The interrelationship between thallium and potassium in animals. J Pharmacol Exp Therap. 1967;155:187-201.
12. Som P, Matsui K, Atkins HL, Lebowitz E, et al. Microautoradiographic studies on the cellular localization of radiothallium. J Nucl Med. 1978;17:266-269.
13. Strauss HW, Harrison K, Pitt B. Thallium-201: non-invasive determination of the regional distribution of cardiac output. J Nucl Med. 1977;18:1167-1170.
14. Atkins HL, Budinger TF, Lebowitz E, et al. Thallium-201 for medical use. Part 3. Human distribution and physical imaging properties. J Nucl Med. 1977;18: 133-140.
15. Charkes ND, Siegel JA. An analytical solution set for a four-compartment mixed mammillary/catenary model. Nucl Med Commun. 1999;20:575-580.
16. Bartlett RD, Lathrop KA, Faulhaber PF, Harper PV. Transfer of thallous ion to and from gastrointestinal sections [abstract]. J Nucl Med. 1984;25(suppl):P92.
17. Krahwinkel W, Herzog H, Feinendegen LE. Pharmacokinetics of thallium-201 in normal individuals after routine myocardial scintigraphy. J Nucl Med. 1988;29: 1582-1586.
18. 201Tl-Labelled TlCl dosimetry revisited. Nucl Med Commun. 1993;14:104-107.
19. ICRP. Radiation Dose to Patients from Radiopharmaceuticals. Publication 53. The International Commission on Radiation Protection. New York, NY: Pergamon Press; 1987; Thallium 201-Tl:371-373.
20. ICRP. Radiation Dose to Patients from Radiopharmaceuticals: Addendum 2 to ICRP Publication 53. Publication 80. The International Commission on Radiation Protection. New York, NY: Pergamon Press; 1998; Thallium 201-Tl:83.
21. Gupta SM, Herrera N, Spencer RP, et al. Testicular-scrotal content of Tl-201 and Ga-67 after intravenous administration. Int J Nucl Med Biol. 1981;8:211-213.
22. Hosain P, Hosain F. Revision of gonadal radiation dose to man from thalium-201. In: Watson EE, Schlafke-Stelson AT, Coffey JL, Cloutier RJ, eds. Proceedings of the Third International Radiopharmaceutical Dosimetry Symposium. Rockville. MD: U.S. Department of Health and Human Services; 1981:333-345.
23. Rao DV, Shepstone BJ, Wilkins HB, Howell RW. Kinetics and dosimetry of thallium-201 in human testes. J Nucl Med. 1995;36:607-609.
24. Nettleton JS, Lawson RS, Prescott MC, Morris ID. Uptake, localization, and dosimetry of In-111 and Tl-201 in human testes. J Nucl Med. 2004;45:138-146.
25. Stabin MG, Thomas SR, Wilson RA, et al. Uptake of Tl-201 in the testes: implications for radiation dosimetry [abstract]. J Nucl Med. 1995;36(suppl):97P.
26. Rao DV, Govelitz GF, Sastry KSR. Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry. J Nucl Med. 1983;24:145-153.
27. Loevinger R, Berman M. A Revised Schema for Calculating Absorbed Dose from Biologically Distributed Radionuclides. MIRD Pamphlet No. 1. Revised. New York, NY: Society of Nuclear Medicine; 1976.
28. Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculations. Revised ed. New York, NY: Society of Nuclear Medicine; 1991.
29. Weber DA, Eckerman KF, Dillman LT, Ryman JC. MIRD: Radionuclide Data and Decay Schemes. New York, NY: Society of Nuclear Medicine; 1989.
30. ICRP. Limits for Intakes of Radionuclides by Workers. Publication 30. The International Commission on Radiation Protection. New York, NY: Pergamon Press; 1979.
31. SigmaPlot 8.0. Chicago, IL: SPSS Science Marketing Department, SPSS Inc.
32. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 1996;37:538-546.
33. Cloutier R, Smith S, Watson E, Snyder W, Warner G. Dose to the fetus from radionuclides in the bladder. Health Phys. 1973;25:147-161.
34. Cristy M, Eckerman K. Specific Absorbed Fractions of Energy at Various Ages from Internal Photon Sources. ORNL/TM-8381 V1-V7. Oak Ridge, TN: Oak Ridge National Laboratory; 1987.
35. Stabin MG, Stubbs JB, Toohey RE. Radiation Dose Estimates for Radiopharmaceuticals. NUREG/CR-6345. Lisle, IL: Nuclear Regulatory Commission; 1996.